ES3065864T3 - Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof - Google Patents

Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof

Info

Publication number
ES3065864T3
ES3065864T3 ES20708183T ES20708183T ES3065864T3 ES 3065864 T3 ES3065864 T3 ES 3065864T3 ES 20708183 T ES20708183 T ES 20708183T ES 20708183 T ES20708183 T ES 20708183T ES 3065864 T3 ES3065864 T3 ES 3065864T3
Authority
ES
Spain
Prior art keywords
diazabicyclo
methyl
octan
pyrazol
methanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20708183T
Other languages
English (en)
Spanish (es)
Inventor
Xiaojing Yang
Amanda Patrice Surajhie Samuel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES3065864T3 publication Critical patent/ES3065864T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
ES20708183T 2019-02-15 2020-02-12 Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof Active ES3065864T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962806180P 2019-02-15 2019-02-15
PCT/IB2020/051128 WO2020165788A1 (en) 2019-02-15 2020-02-12 Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof

Publications (1)

Publication Number Publication Date
ES3065864T3 true ES3065864T3 (en) 2026-05-08

Family

ID=69726639

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20708183T Active ES3065864T3 (en) 2019-02-15 2020-02-12 Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof

Country Status (15)

Country Link
US (2) US12312358B2 (cg-RX-API-DMAC7.html)
EP (1) EP3924355B1 (cg-RX-API-DMAC7.html)
JP (1) JP7561497B2 (cg-RX-API-DMAC7.html)
KR (2) KR102820235B1 (cg-RX-API-DMAC7.html)
CN (1) CN113646310A (cg-RX-API-DMAC7.html)
AR (1) AR118099A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020222083B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021015951A2 (cg-RX-API-DMAC7.html)
CA (1) CA3130034C (cg-RX-API-DMAC7.html)
ES (1) ES3065864T3 (cg-RX-API-DMAC7.html)
MX (1) MX2021009761A (cg-RX-API-DMAC7.html)
SG (1) SG11202108863WA (cg-RX-API-DMAC7.html)
TW (1) TWI820301B (cg-RX-API-DMAC7.html)
WO (1) WO2020165788A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202106815B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102820235B1 (ko) * 2019-02-15 2025-06-16 화이자 인코포레이티드 결정질 피리미디닐-3,8-다이아자바이사이클로[3.2.1]옥타닐메타논 화합물 및 이의 용도
US12673955B2 (en) 2020-06-09 2026-07-07 Crystal Pharmatech Co., Ltd. Crystal form of p-toluenesulfonate salt of diazabicyclic compound and preparation method therefor
CN114835717A (zh) * 2021-02-01 2022-08-02 杭州领业医药科技有限公司 Brepocitinib甲苯磺酸盐的晶型及其制备方法和用途
CN113461687B (zh) * 2021-08-10 2022-04-19 四川大学华西医院 2,8-氮杂-[4,5]十螺环酮衍生物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5023556A (en) 1990-02-02 1991-06-11 Conax Florida Corporation Sensor circuit response to different fluid conductivities and having time delay feature
EA027879B1 (ru) 2013-02-22 2017-09-29 Пфайзер Инк. ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-РОДСТВЕННЫХ КИНАЗ (JAK)
NO2721710T3 (cg-RX-API-DMAC7.html) 2014-08-21 2018-03-31
KR20260080448A (ko) * 2018-03-30 2026-06-02 인사이트 코포레이션 Jak 억제제를 사용하는 화농성 한선염의 치료
KR102820235B1 (ko) * 2019-02-15 2025-06-16 화이자 인코포레이티드 결정질 피리미디닐-3,8-다이아자바이사이클로[3.2.1]옥타닐메타논 화합물 및 이의 용도

Also Published As

Publication number Publication date
TWI820301B (zh) 2023-11-01
CA3130034C (en) 2023-12-19
US20220144846A1 (en) 2022-05-12
ZA202106815B (en) 2026-03-25
JP2020138960A (ja) 2020-09-03
EP3924355B1 (en) 2025-12-31
KR102820235B1 (ko) 2025-06-16
SG11202108863WA (en) 2021-09-29
AU2020222083A1 (en) 2021-09-02
EP3924355A1 (en) 2021-12-22
EP3924355C0 (en) 2025-12-31
JP7561497B2 (ja) 2024-10-04
KR20240116855A (ko) 2024-07-30
CA3130034A1 (en) 2020-08-20
AU2020222083B2 (en) 2022-11-17
AR118099A1 (es) 2021-09-15
US20250282789A1 (en) 2025-09-11
US12312358B2 (en) 2025-05-27
TW202045511A (zh) 2020-12-16
MX2021009761A (es) 2021-12-15
CN113646310A (zh) 2021-11-12
BR112021015951A2 (pt) 2021-10-05
KR20210114470A (ko) 2021-09-23
WO2020165788A1 (en) 2020-08-20

Similar Documents

Publication Publication Date Title
IL288816A (en) Aminobenzazepine compounds, immunoconjugates and uses thereof
IL276802B1 (en) Transduced 2,1-dihydro-3h-pyrazolo[4,3-d]pyrimidine-3-ones
IL285302A (en) Compounds, preparations and methods
IL290781A (en) rip1 inhibitory compounds and methods for their preparation and use
IL276660B1 (en) Herbicidal preparations of 3-azaspiro[5.5]undecaine-8,10-dione
IL284765A (en) 8,1-naphthyridinone compounds and their uses
SG11202006994XA (en) Antibacterial compounds, compositions thereof, and methods using same
EP3924355C0 (en) COMPOUND OF PYRIMIDINYL-3,8-DIAZABICYCLO [3.2.1] CRYSTALLINE OCTANYLMETHANONE AND ITS USE
GB201915831D0 (en) Compounds, compositions and therapeutic uses thereof
SG11202008531RA (en) Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof
ZA202107499B (en) Compounds, compositions and methods
ES3065178T3 (en) Biocidal polyamide-compositions, methods for preparing the same and uses thereof
GB202015822D0 (en) 66.123.142648/01
SG11202104371XA (en) 1,3,4-oxadiazolone compound and pharmaceutical
GB201915828D0 (en) Compounds, compositions and therapeutic uses thereof
ZA202204747B (en) D-amphetamine compounds, compositions, and processes for making and using the same
ZA202107832B (en) Pyrrole amidopyridone compound, preparation method therefor and use thereof
EP4007578A4 (en) SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGS THEREOF AND METHODS THEREOF
PL3750893T3 (pl) Związek dioksazoliny, sposób jego wytwarzania oraz jego zastosowania
IL289141A (en) Compounds 7,8 dihydro-4h-pyrazolo[3,4-c]azepin-6-one
EP4003200A4 (en) ANTIBACTERIAL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF
GB202002560D0 (en) Crystalline forms of voxelotor, and processes for the preparation thereof
HK40072132A (en) Macromolecule-supported thienoazepine compounds, and uses thereof
HK40067178A (en) Aminobenzazepine compounds, immunoconjugates, and uses thereof
HK40047150A (en) Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same